Alzamend Neuro Inc (ALZN) — Strategic Asset Allocation Index
Alzamend Neuro Inc (ALZN) has a Strategic Asset Allocation Index of 2.6% as of April 2023. Strategic assets (PP&E of $79.84K plus long-term investments of $-) total $79.84K, measured against net assets of $3.05 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Alzamend Neuro Inc Strategic Asset Allocation Index (2022–2023)
This chart shows how Alzamend Neuro Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2022 to 2023. As of April 2023, the index stands at 2.6%, representing strategic assets of $79.84K against net assets of $3.05 Million USD. Explore Alzamend Neuro Inc (ALZN) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Alzamend Neuro Inc (2022–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Alzamend Neuro Inc from 2022 to 2023, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Alzamend Neuro Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 2.6% | $79.84K | $79.84K | $- | $3.05 Million | ▲ +1.9 pp |
| 2022 | 0.8% | $102.91K | $102.91K | $- | $13.35 Million | — |